Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer

Journal of Surgical Oncology

Volumn 100, Issue 2, 2009, Pages 111-114

  Ichikawa, Daisuke ^a   Kubota, Takeshi ^a   Kikuchi, Shojiro ^a   Fujiwara, Hitoshi ^a   Konishi, Hirotaka ^a   Tsujiura, Masahiro ^a   Ikoma, Hisashi ^a   Nakanishi, Masayoshi ^a   Okamoto, Kazuma ^a   Sakakura, Chohei ^a   Ochiai, Toshiya ^a   Kokuba, Yukihito ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Invasion; Lymphatic vessel; Prognostic factors; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFANT; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 67749133794     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21311     Document Type: Article

References (15)

1. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Hermanek P, Sobin LH: UICC TNM Classification of malignant tumors. 4th edition. New York: Springer-Verlag; 1992.
3. Japanese Gastric Cancer Association: Japanese classification for gastric carcinoma. 2nd English Edition. Gastric Cancer 1998;1: 10-24.
4. Maehara Y, Tomoda M, Tomisaki S, et al.: Surgical treatment and outcome for node-negative gastric cancer. Surgery 1997;121: 633-639. (Pubitemid 27251902)
5. Ishigami S, Natsugoe S, Hokita S, et al.: Carcinomatous lymphatic invasion in early gastric cancer invading into the subserosa. Ann Surg Oncol 1999;6:286-289. (Pubitemid 29221015)
6. Dicken BJ, Graham K, Hamilton SM, et al.: Lymphovascular invasion is associated with poor survival in gastric cancer - An application of gene-expression and tissue array techniques-. Ann Surg 2006;243:64-73. (Pubitemid 43054056)
7. Lee CC,Wu CW, Lo SS, et al.: Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol 2007; 22:1014-1018. (Pubitemid 47019842)
8. Sakuramoto S, Sasako M, Yamaguchi T, et al.: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. Lymphatic invasion. N Engl J Med 2007;357:1810-1820. (Pubitemid 350044801)
9. Nakajima T, Kinoshita T, Nashimoto A, et al.: Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Cancer 2007;94:1468-1476. (Pubitemid 350275624)
10. Nathanson SD: Insights into the mechanisms of lymph node metastasis. Cancer 2003;98:413-423. (Pubitemid 36828469)
11. Da MX, Wu Z, Tian HW: Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch Med Res 2008;39:365-372.
12. Kunisaki C, Akiyama H, Nomura M, et al.: Lymph node status in patients with submucosal gastric cancer. Ann Surg Oncol 2006; 13:1364-1371.
13. Li C, Kim S, Lai JF, et al.: Risk factors for lymph node metastasis in undifferentiated early gastric cancer. Ann Surg Oncol 2008; 15:764-769.
14. Miyazaki J, Hokari R, Kato S, et al.: Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. Oncol Rep 2002;9:1307-1312.
15. Wang Z, He YL, Cai SR, et al.: Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: Its molecular mechanism was investigated using artificial microRNA interference. Int J Cancer 2008;123:1439-1447.